| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.86B | 34.20B | 34.22B | 33.76B | 30.47B | 32.46B |
| Gross Profit | 11.38B | 9.80B | 8.45B | 8.88B | 7.99B | 11.07B |
| EBITDA | 7.38B | 8.99B | 8.63B | 8.65B | 7.07B | 9.89B |
| Net Income | 3.23B | 2.78B | 2.42B | 2.76B | 2.70B | 5.36B |
Balance Sheet | ||||||
| Total Assets | 81.64B | 82.02B | 69.51B | 68.80B | 64.24B | 52.55B |
| Cash, Cash Equivalents and Short-Term Investments | 8.70B | 8.58B | 6.84B | 5.85B | 7.08B | 9.55B |
| Total Debt | 27.19B | 26.73B | 13.32B | 18.50B | 17.34B | 10.49B |
| Total Liabilities | 43.77B | 44.35B | 34.61B | 35.51B | 33.40B | 23.17B |
| Stockholders Equity | 32.76B | 32.08B | 30.29B | 28.93B | 27.45B | 26.73B |
Cash Flow | ||||||
| Free Cash Flow | 5.19B | 3.99B | 1.44B | 1.39B | -3.15B | 1.37B |
| Operating Cash Flow | 7.66B | 6.55B | 5.98B | 6.24B | 4.57B | 7.59B |
| Investing Cash Flow | -7.30B | -8.49B | -3.67B | -6.45B | -8.38B | -6.79B |
| Financing Cash Flow | 1.15B | 2.63B | -1.47B | -951.75M | 1.77B | -632.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | HK$39.69B | 11.73 | 10.24% | 4.82% | 10.08% | 33.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$116.23B | 16.65 | 4.06% | 4.59% | -9.32% | 5.05% | |
51 Neutral | HK$9.01B | -12.35 | 0.40% | 1.52% | -8.52% | -48.51% | |
50 Neutral | HK$12.84B | 17.29 | 6.91% | 1.29% | 15.17% | 39.36% | |
48 Neutral | HK$739.99M | 2.64 | 2.06% | ― | 0.18% | ― | |
45 Neutral | HK$1.65B | -2.38 | -5.53% | ― | -20.28% | -604.87% |